{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:52:56Z","timestamp":1794585176741,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is a kind of systemic musculoskeletal disorder and a most important factor for causing disability and physical painfulness. Nevertheless, due to the fact that OA can be triggered by multiple etiological factors, this disease is hard to be cured. Therefore, it is of great necessity for us to find novel targets or drugs for OA treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>The chondrocytes were treated with lipopolysaccharide (LPS) and adenosine triphosphate (ATP) to induce pyroptosis in OA. The cell proliferation was detected by Cell Counting Kit-8 assay (CCK-8 assay). Enzyme-linked immunosorbent assay (ELISA) was used for the detection of pyroptosis-related inflammatory factors. Then, the antagonists for gasdermin D (GSDMD) (disulfiram) and high mobility group box 1 (HMGB1) (glycyrrhizic acid) were used to treat the cell model to observe the effects of disulfiram and glycyrrhizic acid on the proliferation of chondrocytes in OA. The protein levels of pyroptosis-related inflammatory factors were measured by western blot, and the levels of aldehyde dehydrogenase (ALDH) and reactive oxygen species (ROS) were measured by corresponding commercial kits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After chondrocytes were induced by LPS and ATP, the cell proliferation was decreased and the expressions of pyroptosis-related inflammatory factors were increased. Disulfiram and glycyrrhizic acid treatment led to enhanced cell proliferation and increased expressions of pyroptosis-related inflammatory factors, while disulfiram showed better alleviative effects on the inflammation in chondrocytes in OA. However, co-treatment with disulfiram at a high concentration and glycyrrhizic acid did not result in higher proliferation of chondrocytes and alleviated inflammation, but led to oxidative stress.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, co-treatment with disulfiram and glycyrrhizic acid at a standard concentration suppresses the inflammatory response of chondrocytes, which may provide guidance for the use of the drugs in the treatment of OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-021-02262-3","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T12:16:44Z","timestamp":1613132204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes"],"prefix":"10.1186","volume":"16","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"2262_CR1","doi-asserted-by":"crossref","unstructured":"Kumar A, Palit P, Thomas S, Gupta G, Ghosh P, Goswami RP, et al. Osteoarthritis: prognosis and emerging therapeutic approach for disease management. Drug Dev Res. 2020.","DOI":"10.1002\/ddr.21741"},{"issue":"8","key":"2262_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.1780380817","volume":"38","author":"SA Oliveria","year":"1995","unstructured":"Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995;38(8):1134\u201341.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"2262_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00223-014-9917-9","volume":"95","author":"B Xia","year":"2014","unstructured":"Xia B, Di C, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95(6):495\u2013505.","journal-title":"Calcif Tissue Int."},{"key":"2262_CR4","doi-asserted-by":"crossref","unstructured":"Kandahari AM, Yang X, Dighe AS, Pan D, Cui Q. Recognition of immune response for the early diagnosis and treatment of osteoarthritis. J Immunol Res. 2015;2015:192415.","DOI":"10.1155\/2015\/192415"},{"issue":"8","key":"2262_CR5","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/jcp.25716","volume":"232","author":"E Belluzzi","year":"2017","unstructured":"Belluzzi E, El Hadi H, Granzotto M, Rossato M, Ramonda R, Macchi V, et al. Systemic and local adipose tissue in knee osteoarthritis. J Cell Physiol. 2017;232(8):1971\u20138.","journal-title":"J Cell Physiol."},{"issue":"2","key":"2262_CR6","first-page":"312","volume":"32","author":"TW O'Neill","year":"2018","unstructured":"O'Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis. Best practice & research. Clin Rheumatol. 2018;32(2):312\u201326.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2262_CR7","first-page":"5463","volume":"17","author":"LR Zhao","year":"2018","unstructured":"Zhao LR, Xing RL, Wang PM, Zhang NS, Yin SJ, Li XC, et al. NLRP1 and NLRP3 inflammasomes mediate LPS\/ATPinduced pyroptosis in knee osteoarthritis. Mol Med Rep. 2018;17(4):5463\u20139.","journal-title":"Mol Med Rep."},{"issue":"5","key":"2262_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1039\/C9MD00059C","volume":"10","author":"A Pandeya","year":"2019","unstructured":"Pandeya A, Li L, Li Z, Wei Y. Gasdermin D (GSDMD) as a new target for the treatment of infection. Medchemcomm. 2019;10(5):660\u20137.","journal-title":"Medchemcomm."},{"issue":"7575","key":"2262_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666\u201371.","journal-title":"Nature."},{"issue":"7575","key":"2262_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660\u20135.","journal-title":"Nature."},{"issue":"7610","key":"2262_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535(7610):111\u20136.","journal-title":"Nature."},{"issue":"3","key":"2262_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","volume":"22","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 2018;22(3):263\u201377.","journal-title":"Expert Opin Ther Targets."},{"key":"2262_CR13","doi-asserted-by":"crossref","unstructured":"Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1. Front Immunol. 2020;11:484.","DOI":"10.3389\/fimmu.2020.00484"},{"key":"2262_CR14","doi-asserted-by":"crossref","unstructured":"Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139\u201362.","DOI":"10.1146\/annurev-immunol-030409-101323"},{"issue":"12","key":"2262_CR15","first-page":"7122","volume":"24","author":"CH Shen","year":"2020","unstructured":"Shen CH, Ma ZY, Li JH, Li RD, Tao YF, Zhang QB, et al. Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K\/mTOR pathway in lipopolysaccharide-induced acute liver injury. Eur Rev Med Pharmacol Sci. 2020;24(12):7122\u201330.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"20","key":"2262_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12935-020-01289-6","volume":"29","author":"Y Yang","year":"2020","unstructured":"Yang Y, Yang L, Jiang S, Yang T, Lan J, Lei Y, et al. HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cells. Cancer Cell Int. 2020;29(20):205.","journal-title":"Cancer Cell Int."},{"issue":"1","key":"2262_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-020-00950-x","volume":"13","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang Y. HMGB1 in inflammation and cancer. J Hematol Oncol. 2020;13(1):116.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"2262_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19(1):107\u201320.","journal-title":"Cell Death Differ."},{"issue":"5","key":"2262_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013\u201322.","journal-title":"Cell."},{"issue":"12","key":"2262_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/jmcb\/mjz020","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang Y, Shi P, Chen Q, Huang Z, Zou D, Zhang J, et al. Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation. J Mol Cell Biol. 2019;11(12):1069\u201382.","journal-title":"J Mol Cell Biol."},{"issue":"11","key":"2262_CR21","first-page":"2271","volume":"33","author":"CF Dillon","year":"2006","unstructured":"Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006;33(11):2271\u20139.","journal-title":"J Rheumatol."},{"issue":"1","key":"2262_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26\u201335.","journal-title":"Part II. Arthritis Rheum."},{"key":"2262_CR23","doi-asserted-by":"crossref","unstructured":"Kolasinski S, Neogi T, Hochberg M, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res. 2020;72(2):149\u201362.","DOI":"10.1002\/acr.24131"},{"key":"2262_CR24","unstructured":"Chow YY, Chin KY. The role of inflammation in the pathogenesis of osteoarthritis. Mediators Inflamm. 2020;2020:8293921."},{"issue":"5","key":"2262_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nri.2016.153","volume":"17","author":"S Nagata","year":"2017","unstructured":"Nagata S, Tanaka M. Programmed cell death and the immune system. Nat Rev Immunol. 2017;17(5):333\u201340.","journal-title":"Nat Rev Immunol."},{"key":"2262_CR26","doi-asserted-by":"crossref","unstructured":"Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137\u201361.","DOI":"10.1146\/annurev-cellbio-101011-155745"},{"issue":"4","key":"2262_CR27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","volume":"73","author":"SL Fink","year":"2005","unstructured":"Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907\u201316.","journal-title":"Infect Immun."},{"key":"2262_CR28","doi-asserted-by":"crossref","unstructured":"Xu Y-J, Zheng L, Hu Y-W, et al. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28\u201337.","DOI":"10.1016\/j.cca.2017.11.005"},{"issue":"16","key":"2262_CR29","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15252\/embj.201694696","volume":"35","author":"L Sborgi","year":"2016","unstructured":"Sborgi L, Ruhl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016;35(16):1766\u201378.","journal-title":"EMBO J."},{"key":"2262_CR30","doi-asserted-by":"crossref","unstructured":"Liu Z, Gan L, Xu Y, Luo D, Ren Q, Wu S, et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-kappaB\/GSDMD signal in mice adipose tissue. J Pineal Res. 2017;63(1):e12414.","DOI":"10.1111\/jpi.12414"},{"issue":"1","key":"2262_CR31","doi-asserted-by":"publisher","first-page":"F96","DOI":"10.1152\/ajprenal.00351.2019","volume":"318","author":"Y Li","year":"2020","unstructured":"Li Y, Xia W, Wu M, Yin J, Wang Q, Li S, et al. Activation of GSDMD contributes to acute kidney injury induced by cisplatin. Am J Physiol Renal Physiol. 2020;318(1):F96\u2013F106.","journal-title":"Am J Physiol Renal Physiol."},{"key":"2262_CR32","doi-asserted-by":"crossref","unstructured":"Hua S, Ma M, Fei X, Zhang Y, Gong F, Fang M. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated Kupffer cells pyroptosis. Int Immunopharmacol. 2019;68:145\u201355.","DOI":"10.1016\/j.intimp.2019.01.002"},{"issue":"1","key":"2262_CR33","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","volume":"11","author":"M Karmakar","year":"2020","unstructured":"Karmakar M, Minns M, Greenberg EN, Diaz-Aponte J, Pestonjamasp K, Johnson JL, et al. N-GSDMD trafficking to neutrophil organelles facilitates IL-1beta release independently of plasma membrane pores and pyroptosis. Nat Commun. 2020;11(1):2212.","journal-title":"Nat Commun."},{"issue":"1","key":"2262_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1124\/jpet.111.182592","volume":"339","author":"M Ogiku","year":"2011","unstructured":"Ogiku M, Kono H, Hara M, Tsuchiya M, Fujii H. Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats. J Pharmacol Exp Ther. 2011;339(1):93\u20138.","journal-title":"J Pharmacol Exp Ther."},{"issue":"9","key":"2262_CR35","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ijc.27482","volume":"131","author":"C Conticello","year":"2012","unstructured":"Conticello C, Martinetti D, Adamo L, Buccheri S, Giuffrida R, Parrinello N, et al. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies. Int J Cancer. 2012;131(9):2197\u2013203.","journal-title":"Int J Cancer."},{"issue":"1","key":"2262_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/jam.14094","volume":"126","author":"KR Frazier","year":"2019","unstructured":"Frazier KR, Moore JA, TE. Long, antibacterial activity of disulfiram and its metabolites. J Appl Microbiol. 2019;126(1):79\u201386.","journal-title":"J Appl Microbiol."}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-021-02262-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T12:20:12Z","timestamp":1613132412000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02262-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02262-3","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}